ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How Life Sciences Leaders Are Preparing For More Curveballs In 2026

  Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.

• Five Key Trends In CMC

  CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.

• The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective

  Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.

• 3 Reasons Sponsors Should Own The RTSM Vendor Relationship

  Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.

• End-To-End Inventory Control Supports Biotech's Expanding Portfolio

  Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.

• Avoiding The Risk Of A Non-Transparent Clinical Supply Solution

  With the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.

• Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It

  Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.

• Specializing In Small And Early-Stage Partners, Not Just Small Batches

  Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.

• Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials

  Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.

• When Protocol Amendments Meet RTSM: From Headache To High-Performance

  Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.